US5654176AExpiredUtility

Fusion proteins containing glutathione-s-transferase

81
Assignee: AMRAD CORP LTDPriority: May 28, 1987Filed: Sep 16, 1994Granted: Aug 5, 1997
Est. expiryMay 28, 2007(expired)· nominal 20-yr term from priority
Inventors:Donald B. Smith
C12N 15/62C07K 2319/23C07K 2319/50
81
PatentIndex Score
65
Cited by
59
References
25
Claims

Abstract

A recombinant DNA molecule comprising a nucleotide sequence which codes for expression of a fusion protein in which a foreign protein or peptide is fused with the enzyme glutathione-S-transferase, is disclosed, as well as expression vectors or host cells containing such a molecule. Optionally, the foreign protein or peptide is fused to the enzyme through a cleavable link. Also disclosed is an expression vector having inserted therein a nucleotide sequence capable of being expressed as the enzyme glutathione-S-transferase followed by at least one restriction endonuclease recognition site for insertion of a nucleotide sequence capable of being expressed as a foreign protein or peptide fused to the glutathione-S-transferase.

Claims

exact text as granted — not AI-modified
I claim: 
     
       1. A recombinant DNA molecule comprising a nucleotide sequence which codes for a fusion protein wherein said fusion protein comprises glutathione-S-transferase and a second protein or peptide fused directly or indirectly with the COOH-terminus of glutathione-S-transferase, and wherein said fusion protein is capable of binding to glutathione. 
     
     
       2. The recombinant DNA molecule according to claim 1, wherein said glutathione-S-transferase is the 26kDa glutathione-S-transferase of Schistosoma japonicum. 
     
     
       3. The recombinant DNA molecule according to claim 1 wherein said second protein or peptide is fused to said glutathione-S-transferase through a cleavable link. 
     
     
       4. The recombinant DNA molecule according to claim 3, wherein said cleavable link is cleavable by a site specific protease. 
     
     
       5. The recombinant DNA molecule according to claim 4, wherein said clearable link is cleavable by thrombin, blood coagulation factor X a  or renin. 
     
     
       6. The recombinant DNA molecule of claim 1 wherein said glutathione-S-transferase is a mammalian glutathione-S-transferase. 
     
     
       7. An expression vector comprising the recombinant DNA molecule of any one of claims 1, 2-5 and 6. 
     
     
       8. A host cell comprising the expression vector of claim 7. 
     
     
       9. The host cell of claim 8 wherein said host cell is a bacterial cell. 
     
     
       10. The host cell according to claim 9 which is E. coli. 
     
     
       11. An expression vector comprising, in the 5' to 3' direction, a promoter, a nucleotide sequence encoding glutathione-S-transferase and a nucleotide sequence comprising at least one restriction endonuclease recognition site. 
     
     
       12. The expression vector according to claim 11, wherein said glutathione-S-transferase is the 26kDa glutathione-S-transferase of Schistosoma japonicum. 
     
     
       13. The expression vector according to claim 11, which comprises a plasmid selected from the group consisting of pGEX-1, pSj10 DBamI and pSj10 DBam7Stop7. 
     
     
       14. An expression vector comprising, in the 5' to 3' direction, a promoter, a nucleotide sequence encoding glutathione-S-transferase, a nucleotide sequence encoding a clearable link and a nucleotide sequence comprising at least one restriction endonuclease recognition site. 
     
     
       15. The expression vector according to claim 14, wherein said cleavable link is cleavable by a site specific protease. 
     
     
       16. The expression vector according to claim 14 which is pGEX-2T or pGEX-3X. 
     
     
       17. The plasmid pGEX-1. 
     
     
       18. The plasmid pGEX-2T. 
     
     
       19. The plasmid pGEX-3X. 
     
     
       20. A method of producing a fusion protein comprising glutathione-S-transferase and a second protein or peptide fused directly or indirectly with the COOH-terminus of glutathione-S-transferase which comprises: (a) transforming a host cell with an expression vector comprising a promoter operatively linked to a nucleotide sequence which codes for a fusion protein wherein said fusion protein comprises glutathione-S-transferase and a second protein or peptide fused directly or indirectly with the COOH-terminus of glutathione-S-transferase and wherein said fusion protein is capable of binding to glutathione;   (b) culturing said host cell under conditions such that said fusion protein is expressed in recoverable quantity;   (c) lysing said host cell; and   (d) purifying said fusion protein by glutathione-affinity chromatography.   
     
     
       21. A method of producing a protein or peptide which comprises: (a) transforming a host cell with an expression vector comprising a promoter operatively linked to a nucleotide sequence which codes for a fusion protein wherein said fusion protein comprises glutathione-S-transferase and a second protein or peptide fused with the COOH-terminus of glutathione-S-transferase through a cleavable link wherein said fusion protein is capable of binding to glutathione;   (b) culturing said host cell under conditions such that said fusion protein is expressed in recoverable quantity;   (c) lysing said host cell;   (d) purifying said fusion protein by glutathione-affinity chromatography;   (e) cleaving said protein or said peptide from said glutathione-S-transferase; and   (f) isolating said protein or said peptide.   
     
     
       22. A fusion protein comprising glutathione-S-transferase and a second protein or peptide fused directly or indirectly with the COOH-terminus of said glutathione-S-transferase wherein said fusion protein is capable of binding to glutathione. 
     
     
       23. A fusion protein comprising from amino to carboxyl terminus, glutathione-S-transferase, a cleavable linker and a second protein or peptide wherein said fusion protein is capable of binding to glutathione. 
     
     
       24. The fusion protein of claim 23 wherein said cleavable linker is cleavable by a site-specific protease. 
     
     
       25. The fusion protein of claim 24 wherein said protease is selected from the group consisting of thrombin, blood coagulation Factor Xa and renin.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.